RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
THE LANCET. HAEMATOLOGY
Collezione AO Cuneo

Items : 4

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. in The Lancet. Haematology / Lancet Haematol. 2020 Jun;7(6):e456-e468. doi: 10.1016/S2352-3026(20)30099-5. Epub 2020 Apr 30.

2020
AOU Città della Salute di Torino
AO Cuneo

Sonneveld P; Boccadoro M; Carvalho S; Spencer A; Palmas A; Cafro AM; Minnema M; Mandigers C; van Marwijk Kooy M; Gimsing P; Mellqvist UH; Waage A; Driessen C; Specchia G; Zander T; Caravita di Toritto T; Durian M; von dem Borne PA; Hajek R; Wu KL; Boersma R; Morelli AM; Aquino S; Ludwig H; Levin MD; Bos G; Pascarella A; Benevolo G; Troia R; et alii...

Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. in The Lancet. Haematology / Lancet Haematol. 2019 Feb;6(2):e89-e99. doi: 10.1016/S2352-3026(18)30214-X.

2019
AO Cuneo

Heinzelmann M; Benedetti F; Milone G; Benedetti E; Russo D; Sierra J; Sorasio R; Ferra C; Finke J; Guidi S; Cimminiello M; Carella AM; Sureda A; Herrera P; Bethge W; Messina G; Risitano AM; Selleri C; Nagler A; Zallio F; Patriarca F; Sessa M; Wolschke C; Solano C; Bonifazi F; Pastore D; Jurado M; Terruzzi E; Narni F; et alii...

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study. in The Lancet. Haematology / Lancet Haematol. 2016 Oct;3(10):e467-e479. doi: 10.1016/S2352-3026(16)30108-9.

2016
AO Cuneo
AOU Città della Salute di Torino

Pileri SA; d'Amore F; Zinzani PL; Gascoyne RD; Broccoli A; Argnani L; Steidl C; Subocz E; Rybka J; Tajer J; Kulikowski W; Zaucha JM; Hamilton-Dutoit S; Kamper P; Piccaluga PP; Borra A; Stelitano C; Trentin L; Patti C; Romano A; Levis A; Merli F; Vitolo U; Rigacci L; Biggi A; Sista MT; Fanti S; Fuligni F; Agati P; et alii...